Ingrid Delaet, Chief Regulatory Officer at Neurocrine Biosciences, sold NBIX on Jul 7, 2026
Data as of Oct 16
▼ SELL$607K3,401 shares at $178.57Ingrid Delaet Chief Regulatory OfficerNBIX Neurocrine Biosciences Inc
- Traded
- Jul 7, 2026
- Disclosed
- Jul 9, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
NBIX since disclosure
−24.8%
after the sale
Similar stocks (XLV) since disclosure
+9.0%
XLV — its sector index fund
Change in closing price from Jul 9, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLIngrid Delaet Chief Regulatory OfficerNBIX Neurocrine Biosciences Inc$1.5Mdisclosed Jul 9 · filed the same day
- ▼ SELLIngrid Delaet Chief Regulatory OfficerNBIX Neurocrine Biosciences Inc$489Kdisclosed Jul 9 · filed 1 day after the trade